Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study

Title
Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study
Authors
Keywords
Cardiotoxicity, Elderly, Neoadjuvant chemotherapy, Pegylated liposomal doxorubicin, Breast cancer, Phase II study
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 151, Issue 3, Pages 597-606
Publisher
Springer Nature
Online
2015-05-15
DOI
10.1007/s10549-015-3415-2

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started